Cargando…
Excess mortality during the Coronavirus disease pandemic in Korea
BACKGROUND: Although the ongoing epidemics of Coronavirus disease 2019 (COVID-19) may have affected the mortality trend of the nation, the national level assessment of excess mortality (changes in overall mortality in the entire population) is still scarce in Korea. Therefore, this study evaluated t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474701/ https://www.ncbi.nlm.nih.gov/pubmed/37660007 http://dx.doi.org/10.1186/s12889-023-16546-2 |
_version_ | 1785100557940162560 |
---|---|
author | Han, Changwoo Jang, Hoyeon Oh, Juhwan |
author_facet | Han, Changwoo Jang, Hoyeon Oh, Juhwan |
author_sort | Han, Changwoo |
collection | PubMed |
description | BACKGROUND: Although the ongoing epidemics of Coronavirus disease 2019 (COVID-19) may have affected the mortality trend of the nation, the national level assessment of excess mortality (changes in overall mortality in the entire population) is still scarce in Korea. Therefore, this study evaluated the excess mortality during the COVID-19 pandemic in Korea using the certified mortality data. METHODS: Monthly mortality and population data from January 2013 to June 2022 was obtained from the National Health Insurance Service database and Statistics Korea. A quasi-Poisson interrupted time-series model adjusted for age structure, population, seasonality, and long-term trends was used to estimate the counterfactual projections (expected) of mortality during the COVID-19 pandemic (March 2020 to June 2022). The absolute difference (observed—expected) and ratio (observed / expected) of mortality were calculated. Stratified analysis based on pandemic years (years 2020, 2021, and 2022), sex, and age groups (aged 0–4, 5–19, 20–64, and ≥ 65 years) were conducted. RESULTS: An 8.7% increase in mortality was observed during the COVID-19 pandemic [absolute difference: 61,277 persons; ratio (95% confidence interval (CI)): 1.087 (1.066, 1.107)]. The gap between observed and estimated mortality became wider with continuation of the pandemic [ratio (95% CI), year 2020: 1.021 (1.003, 1.040); year 2021: 1.060 (1.039, 1.080), year 2022: 1.244 (1.219, 1.270)]. Although excess mortality across sex was similar, the adult [aged 20–64, ratio (95% CI): 1.059 (1.043, 1.076)] and elderly [aged 65-, ratio (95% CI): 1.098 (1.062, 1.135)] population showed increased excess mortality during the pandemic. CONCLUSIONS: Despite Korea's successful quarantine policy response, the continued epidemic has led to an excess mortality. The estimated mortality exceeded the number of deaths from COVID-19 infection. Excess mortality should be monitored to estimate the overall impact of the pandemic on a nation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16546-2. |
format | Online Article Text |
id | pubmed-10474701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104747012023-09-03 Excess mortality during the Coronavirus disease pandemic in Korea Han, Changwoo Jang, Hoyeon Oh, Juhwan BMC Public Health Research BACKGROUND: Although the ongoing epidemics of Coronavirus disease 2019 (COVID-19) may have affected the mortality trend of the nation, the national level assessment of excess mortality (changes in overall mortality in the entire population) is still scarce in Korea. Therefore, this study evaluated the excess mortality during the COVID-19 pandemic in Korea using the certified mortality data. METHODS: Monthly mortality and population data from January 2013 to June 2022 was obtained from the National Health Insurance Service database and Statistics Korea. A quasi-Poisson interrupted time-series model adjusted for age structure, population, seasonality, and long-term trends was used to estimate the counterfactual projections (expected) of mortality during the COVID-19 pandemic (March 2020 to June 2022). The absolute difference (observed—expected) and ratio (observed / expected) of mortality were calculated. Stratified analysis based on pandemic years (years 2020, 2021, and 2022), sex, and age groups (aged 0–4, 5–19, 20–64, and ≥ 65 years) were conducted. RESULTS: An 8.7% increase in mortality was observed during the COVID-19 pandemic [absolute difference: 61,277 persons; ratio (95% confidence interval (CI)): 1.087 (1.066, 1.107)]. The gap between observed and estimated mortality became wider with continuation of the pandemic [ratio (95% CI), year 2020: 1.021 (1.003, 1.040); year 2021: 1.060 (1.039, 1.080), year 2022: 1.244 (1.219, 1.270)]. Although excess mortality across sex was similar, the adult [aged 20–64, ratio (95% CI): 1.059 (1.043, 1.076)] and elderly [aged 65-, ratio (95% CI): 1.098 (1.062, 1.135)] population showed increased excess mortality during the pandemic. CONCLUSIONS: Despite Korea's successful quarantine policy response, the continued epidemic has led to an excess mortality. The estimated mortality exceeded the number of deaths from COVID-19 infection. Excess mortality should be monitored to estimate the overall impact of the pandemic on a nation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16546-2. BioMed Central 2023-09-02 /pmc/articles/PMC10474701/ /pubmed/37660007 http://dx.doi.org/10.1186/s12889-023-16546-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Han, Changwoo Jang, Hoyeon Oh, Juhwan Excess mortality during the Coronavirus disease pandemic in Korea |
title | Excess mortality during the Coronavirus disease pandemic in Korea |
title_full | Excess mortality during the Coronavirus disease pandemic in Korea |
title_fullStr | Excess mortality during the Coronavirus disease pandemic in Korea |
title_full_unstemmed | Excess mortality during the Coronavirus disease pandemic in Korea |
title_short | Excess mortality during the Coronavirus disease pandemic in Korea |
title_sort | excess mortality during the coronavirus disease pandemic in korea |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474701/ https://www.ncbi.nlm.nih.gov/pubmed/37660007 http://dx.doi.org/10.1186/s12889-023-16546-2 |
work_keys_str_mv | AT hanchangwoo excessmortalityduringthecoronavirusdiseasepandemicinkorea AT janghoyeon excessmortalityduringthecoronavirusdiseasepandemicinkorea AT ohjuhwan excessmortalityduringthecoronavirusdiseasepandemicinkorea |